Markedly elevated creatine phosphokinase levels after neuroleptic withdrawal.
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D003402:Creatine Kinase / Q000097:blood*; D004311:Double-Blind Method; D004409:Dyskinesia, Drug-Induced / Q000201:enzymology; D006801:Humans; D007527:Isoenzymes; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000201:enzymology*; D013881:Thioridazine / Q000009:adverse effects* / Q000627:therapeutic use
D007527:Isoenzymes; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase; D013881:Thioridazine